NCT00385190View on ClinicalTrials.gov

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

HCV-796

Trial Locations (1)

108-8642

Minato-ku

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00385190 - Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men | Biotech Hunter | Biotech Hunter